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Literature Review of MPH dissertation 
Dissertation title: Outcomes of HIV early infant diagnosis, a laboratory perspective 
 
Introduction and purpose of the review 
Prevention of mother-to-child transmission (PMTCT) of HIV is the cornerstones of HIV 
prevention programs. The principle of using antiretrovirals (ARV) to reduce the risk of 
transmission from mother to child is well established as a range of PMTCT  regimens with 
varying efficacies have been widely studied  and reviewed1. In South Africa and other Sub-
Saharan countries, single dose Nevirapine, amongst other cost- effective regimens, have been 
adopted as part of the national HIV prevention program2 since 2003.  
The initiation of this lifesaving program, however, is only the beginning of a comprehensive 
care to combat paediatric HIV infection. The traditional PMTCT cascade focuses on the 
identification of HIV infected mothers and delivery of prophylaxis to mother and baby3;4. In 
order to minimise the morbidity and mortality of HIV- infected infants, a strategy for the care 
for all HIV exposed infants are required. Specifically, Infant diagnosis of HIV infection and 
linkage of HIV infected infant to care are among the top priorities of the care for HIV 
exposed infants. This review will outline the evolution of PMTCT regimens in the Western 
Cape Province and focuses on the various aspects of the paediatric HIV programme 
downstream from the provision of PMTCT.  The aim is to provide a background to the 
dissertation which will focus on the outcomes of HIV early infant diagnosis (EID) and 
linkage to care in the province.   
Evolution of PMTCT regimens in the Western Cape Province 
Following the landmark study in Thailand5 where AZT given to pregnant mother from 34 
weeks was shown to reduce the HIV transmission from 18.9% to 9.4%, the provision of AZT 
was piloted in two obstetrics units in Khayelitsha in 1999. This herald the start of pilot 
PMTCT programs in the Western Cape Province. AZT and other single-drug PMTCT such as 










years. It was not until 2003, forced by the constitutional court ruling, the single dose 
Nevirapine regimen was expanded to the rest of South Africa, including the Western Cape 
Province, making the standard of care in line with the WHO guideline7 of single agent 
PMTCT at the time.  
When the availability of highly active antiretroviral therapy (HAART) had become 
increasingly available in adult in 2004, the standard of care for women with advanced HIV 
(WHO stage 3 or 4 or CD4 count less than 200cell/mm3) was to receive HAART. For those 
who are not eligible for HAART, various multi-drug regimens of PMTCT were further rolled 
out in the province. AZT given to pregnant mother from 28 weeks followed by single dose 
Nevirapine at birth became available in the province in 2006. This regimen was subsequently 
adopted in the 2008 National PMTCT guideline2 . By 2009 and 2010, the AZT was further 
extended to be given from 14 week during pregnancy and infant prophylaxis of Nevirapine to 
six weeks post partum (or after cessation of breastfeeding) in the latest iteration of the 
national PMTCT guideline8. These evolutions in the standard of care was in line with the 
revised 2010 WHO guidelines9. 
Despite its very early exposure to PMTCT, the implementation and rollout of the PMTCT 
program in Western Cape is hindered by several factors. On the national level, the HIV 
denialism associated with the government at the time resulted in little political will to 
implement HIV prevention programs. The relative high cost of ARV in the context of 
resource limited setting is another important reason for the slow rollout of PMTCT 
nationally. On the program level, lower coverage of PMTCT in area where access to basic 
health services is a major problem10. This lack of access, due to a combination of skilled staff 
shortage and logistic constraints11, hampers all aspect of the PMTCT cascade from 










On a personal level, the fear of the diagnosis and the stigma associated with HIV12  is among 
reasons that the uptake of counselling and testing service at the antenatal clinic is low. 
PCR as a tool for HIV early infant diagnosis  
Irrespective of the PMTCT program success, early infant diagnosis of HIV infection forms a 
critical part of the care of HIV exposed infants. Offered to infants that are HIV exposed, EID 
uses polymerase chain reaction (PCR) to detect viral genome. Conventional antibody based 
assays cannot be used to reliably diagnose HIV infection in infants if the mother is HIV 
infected. The trans-placental maternal antibody against HIV in the first 18 months of life 
necessitates a direct method of HIV detection. 
PCR is both sensitive and specific13;14 for the detection of paediatric HIV infection, but is 
relatively expensive, requires specialised laboratory equipment, and is technically demanding 
for the laboratory staff. PCR is also a time consuming assay. Despite recent improvement in 
PCR technology, most commercial PCR will take most of one working day to complete. This 
means EID is firmly in the domain of centralised specialist laboratories, and same day 
turnaround time is largely out of reach for the public sector of low and middle income 
countries15;16. 
Importance of EID on paediatric HIV care 
According to the 2011 World Health Organization/Joint United Nations Programme on 
HIV/AIDS/United Nations Children’s Fund (WHO/UNAIDS/UNICEF) statistics, 
approximately 390,000 children acquired HIV infection in 2010. Majority of these HIV 
infections were acquired either perinatally or through breast feeding. Unlike the infection in 
adults, early infant HIV infection often progress rapidly, resulting in mortality of 50% in the 
first year of life17. Fortunately the high mortality associated with early HIV infection can be 
largely mitigated by the administration early antiretroviral therapy (ART)18.  Thus early 










facilitate the timely and appropriate clinical management of disease, leading to improved 
quality of life and reduced infant morbidity and mortality19. 
Logistical issues around EID 
The logistical factors are threats to an efficient EID service in sub-Saharan Africa. For 
laboratories to generate quality results, collection of infant blood samples and transport of the 
samples over long distances in a stable condition is critical. The Kenyan experience showed it 
can take up to three weeks from specimen collection to arrival at the laboratory. To this end, 
protocols of dried blood spot had played a major role in expanding the reach of EID20;21.  
Equally, the timeous return of laboratory results to the health care worker in the absence of IT 
infrastructure is a major challenge. While studies in Botswana showed in an efficient setting, 
a 9 day delay from specimen collection to receipt of result at the facility20  , other African 
studies of more remote rural settings indicate that  it may take on average 3-6 weeks from 
sample collection  to  the  return  of the result to the health facility22;23. 
Return of EID result to caregiver 
 The biggest logistical challenge regarding EID is arguably the return of HIV PCR result to 
the mother or the caregiver of the child. As point-of-care testing is not currently available and 
same-day turnaround time for HIV PCR is not feasible since the caregiver will need to return 
to the facility at a later stage for the PCR result. Accessing health facilities can be a costly 
and time consuming exercise. Few available data in sub-Saharan Africa suggests that many 
caregivers elect not to return for the result of EID.  A study conducted in Kwa-Zulu Natal24 
showed that 43% of the mothers never returned for their children’s PCR result. A study in 
Tanzania showed that not only did 45% of the caregivers failed to return but 14% of the 
caregivers who received the positive PCR result had  done so after their children had 










caregiver, in the case of a positive result, delay in returning result may prove to be fatal for 
the child.  
HIV disease and early antiretroviral therapy in infants 
The main purpose of EID is to triage HIV exposed infants for early intervention. Prior to the 
early HAART era, the WHO recommend26 HIV infected children would received co-
trimoxazole prophylaxis until such time that they are either symptomatically or 
immunologically eligible for ART. This rationale was the convention used for adult ART, 
where ARV was deferred due to both program cost constraint and the intention to limit drug 
toxicity in those that does not yet require ARV. However, the first year of life is a perilous 
period for a peri-natally infected child. A randomised study conducted in Zambia indicated 
that the use of co-trimoxazole prophylaxis had resulted in 43% reduction in mortality in the 
first 19 months of life27. Despite this effective intervention, the mortality rate in the co-
trimoxazole arm was 28%.  Pneumonia, diarrhoeal illness, failure to thrive, BCGosis and 
tuberculosis are amongst the commonest opportunistic illness that present in these children28-
30. The investigating team of the children with early antiretroviral therapy (CHER) study 
challenged the paradigm of deferred antiretroviral in children, arguing that the immature 
immune system of a newborn is at high risk of HIV disease progression and  that early 
HAART may reverse the mortality seen in the early infant life. 
The outcome of CHER study showed that by initiating ART as soon as HIV diagnosis in 
made in the infant (early ART), there was 76% reduction in early mortality and 75% 
reduction in HIV disease progression18. This dramatic effect prompted the release of the new 
WHO paediatric treatment guideline31 in 2010 where early ART is recommended in all 
children less than 24 months of age.  
The South African National guideline on EID and early ART  
The local guideline in South Africa was similarly adjusted to include children under one 










HIV exposed infant to return, the EID visit coincides with the early immunization visit at 6, 
10 and 14 week8. This integration of service makes a lot of sense logistically as it reduces the 
number of postnatal follow ups and allows time for the delay between getting the blood 
sample to the laboratory, HIV PCR testing in the laboratory and returning of result to the 
health facility. The local guideline also stipulated that a confirmation of HIV PCR in the form 
of baseline HIV-1 RNA viral load should be performed at the first ARV visit. Thereafter, 
HIV viral load should be monitored at 6 months and one year after the initiation of HAART. 
For HIV infected infants, the interval between testing and receiving result may be too long 
which results in delay of ART initiation. Some of these children often present at district 
hospitals or even tertiary hospitals with opportunistic infections. In these health facilities, 
HIV PCRs are often performed as part of symptomatic HIV diagnosis. If the HIV diagnosis is 
made in the first year of life, according to the 2010 National guideline, ART should be 
rapidly initiated in these facilities.  
Linked to HIV care 
 Key barriers such as staff training need to be addressed before a smooth paediatric ARV 
program can be delivered. Paediatric ARV had always been initiated by specialised 
paediatricians. In order for early HAART to be widely available, primary health care staff, 
supported by specialists, should be able to initiate and manage infant ARV. Efficient referral 
systems from EID/immunization clinics should be in place so that the delay between 
diagnosis of HIV infection and the initiation of ART is minimised. This may be difficult to 
achieve as recent data from Malawi found that only 320 (30%) of 1084 infant tested HIV 
PCR positive  had enrolled in subsequent HIV care33. Despite good EID turnaround time in 
the Botswana study 20, only 65% of PCR positive infant were linked to care. These studies 
were conducted at a time where the paediatric guidelines were in the process of revision.  










difficulties related to linkage to care. The proportion of PCR positive children linked to care 
for Senegal, Uganda and Cambodia were 22%, 37% and 38% respectively. Lack of efficient 
referral service and poor integration of services are two reasons the proportion of linkage to 
care is low. Further studies in the era of the new guideline will be required to assess whether 
interventions to improve linkage to care is necessary. 
Conclusion 
Ciaranello at al35 suggested that the delivery of early infant diagnosis in the resourced-
constraint setting should be viewed as a cascade where four levels of the service deserves 
individual attention. Firstly, HIV testing should be offered to infants that requires them 
regardless of known HIV exposure and history of PMTCT. Secondly, the specimen must be 
collected, transported and processed effectively. Thirdly, the result must be returned to the 
health care provider, the patient and caregiver promptly. Finally, children should be referred 
to appropriate service for intervention. Currently, there is little published data evaluating the 
performance of the PMTCT and EID program in South Africa. Grimwood and colleagues 
looked at the outcomes of PMTCT at 58 antenatal clinics in three provinces36 . The result is 
encouraging. Proportion of PCR positive infant was reduced by 75.2%. However, little 
systematic data is available on the linkage to care of PCR positive infants. The questions 
remain whether the system is able to delivery the result to the caregiver and refer the infected 
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Prevention of Mother-to-Child Transmission (PMTCT) is a well established HIV prevention 
strategy that had prevented countless infant HIV infection and mortality in sub-Saharan 
Africa. Despite its wide implementation, few studies and surveys are able to effectively 
measure its progress. Centralized laboratories that perform early infant diagnosis of HIV are 
at a unique position to gather data on the progress of PMTCT. 
 
Method:  
We conducted a retrospective cohort study analyzing archived demographic and laboratory 
data from the national pathology service provider, National Health Laboratory Service. All 
test requests of HIV PCR as part of early infant diagnosis program between 2005 and 2011 
were extracted and analysed to monitor progress of program. HIV viral load test requests 
were further extracted with the purpose of linking positive PCR result to subsequent 
virological testing, a proxy for referral to care. 
 
Results:  
A total of 83698 first time early infant test requests were extracted. Overall, 6322 (7.6%) of 
infants tested PCR positive. The proportion of PCR-positive children declined steadily from 
12% in 2005 to 3% in 2011. Our matching algorithm yielded 4105 (65%) children with 
matching positive PCR and viral load testing episodes. The proportion of matched PCR-VL 
improved from 54% in 2005 to 71% in 2010 and the delay between match PCR-VL was 
reduced from 146 days in 2005 to 33 days in 2010. 
 
Discussion: Our data suggest there had been substantial improvement in both the 
effectiveness of PMTCT services and the capacity for referral of infected infants to care. 
However, the large proportion of PCR-positive children who do not appear to be enrolled into 
subsequent HIV care and treatment services is of concern, and warrants further research. 
Although using laboratory data to evaluate program progress has some limitations, it is an 
efficient and readily available resource to monitor HIV programmes and inform health 












Prevention of Mother-to-Child Transmission (PMTCT) programmes are one of the most 
effective means of preventing HIV infection1. In South Africa where an estimated 29.4% of 
pregnant mothers are infected with HIV2, mother-to-child transmission of HIV is associated 
with a large burden of morbidity and mortality. Prior to the implementation of PMTCT 
programmes, early infant mortality was high and a peak in the 2-3 month age group was 
partly attributed to the HIV infection among infants3. Thus PMTCT plays an important role 
in the overall HIV prevention program.  
 
In order to assess the impact of the PMTCT program, direct measures of PMTCT programme 
outcomes are required. However until recently, very little data were available on the efficacy 
of PMTCT in South Africa. An evaluation of 58 antenatal clinic showed the HIV infection 
rate was on the decline4.  In a recent study, Goga and Dinh et al5 conducted a facility- based 
survey of PMTCT efficacy using data from immunization clinics in South Africa. These 
authors found that the mother to child transmission rate to be 3.3% for the Western Cape 
Province and 3.5% for South Africa overall.  
 
Early infant diagnosis (EID) of HIV by polymerase chain reaction (PCR) is a direct measure 
of PMTCT effectiveness. PCR testing is necessary because in infants below 18 months of 
age, maternal antibodies render the conventional rapid test difficult to interpret. Whereas a 
positive rapid test identifies the infant as HIV exposed, a positive PCR identifies the infant as 
HIV infected. This early diagnosis of infant HIV infection allows rapid referral to care. In 
these cases, early initiation of Antiretroviral Therapy (ART) is critical. Violari and colleagues 
demonstrated in the Children with Early Antiretroviral Therapy (CHER) study that while 
HIV infection in the first year of life is associated with high mortality, this can be largely 
mitigated by the administration of early ART6.  
 
For both EID and the subsequent immunological/virological monitoring of infected infants, 
specialised laboratory staff and equipment are required. The prerequisites place EID firmly in 
the domain of a few centralized specialist laboratories. By analyzing laboratory testing data 
for EID, one could gain useful insight into the efficacy of PMTCT and health system issues 
relating to referral to early infant ART. However, there is little published data on the use of 
specialist laboratory data to describe the implementation of early infant diagnosis and 
subsequent referral of HIV-infected infants to paediatric HIV care and treatment services.  
 
The PMTCT and early infant diagnosis program had been provided through a range of 
primary and tertiary health facilities by the provincial Department of Health in Western Cape 
Province since 2001. The provision of the deferred ART was initially based on the 2004 
WHO recommendation on antiretroviral drugs for treating HIV infection in infants in 
resource-constrained settings7. The early infant diagnosis is performed at well baby clinics in 
primary care facilities. Once diagnosis is made, the child is referred to central facility for 
follow up and initiation of ART once eligible. Following the outcome of CHER study in 
2008, early ART gradually became available in the province through the paediatric services 
in their academic centres and their outreach programmes. Baseline HIV viral load was 
performed in all PCR positive infants enrolled into the ART programme. This baseline viral 
load serves as a confirmation of the positive PCR result. 
 
National Health Laboratory Service (NHLS) is a South African national pathology 










NHLS was thus the sole provider of HIV PCR and HIV viral load testing for the provincial 
PMTCT and ART programme. All patient details including health facility data, date of 
testing, demographic detail and test requested were captured from the laboratory request form 
onto the laboratory information system by laboratory clerk prior to testing. This accuracy 
process is monitored by internal reviewing 5% of all test requests. The corporate data 
warehouse (CDW) of NHLS has routinely archived all demographic and laboratory testing 
data from the laboratory information system since 2005. We retrieved data from the archive 
of NHLS CDW on all episodes of HIV PCR and HIV viral load in the Western Cape from 
January 2005 to July 2011. 
 
Methods: 
This study was a retrospective cohort study to evaluate the early infant HIV diagnosis (EID) 
service in the Western Cape Province of South Africa using routine laboratory data. We 
examined the trends in PCR-positive test results and the subsequent referral of infected 
infants based on the availability of HIV viral load test results. The turnaround time between 
PCR diagnosis and subsequent viral load was also assessed in this study. 
  
Yearly data for HIV PCR and HIV viral load were concatenated and non-diagnostic testing 
episodes such as external quality assurance samples were removed from the analysis. Any 
duplicate data were tagged and removed. For HIV PCR, tests with missing results were 
recoded to positive/negative/equivocal, based on best available information in the extracted 
laboratory data or removed from the analysis because the test could not be performed. Serial 
testing of the same individual was identified using a combination of identical folder number, 
surname and/or date of birth. These episodes were tagged and ordered by the date of testing 
and only the first episode of each individual from children less than 2 years of age and the 
HIV viral load results from children less than 5 years of age were included in the analyses. 
Any positive testing episodes that is not the first test is considered repeat testing and therefore 
not included in the analysis to prevent duplication. The facility number allocated to each of 
the infants in western Cape are unique and thus duplication in facility number is not a result 
of different patients in different clinics. 
 
In order to identify the HIV infected infants that were followed up and enrolled into the ART 
programme, we used linked, subsequent HIV viral load testing as a proxy because all infants 
in the ART program in the province received a baseline HIV viral load testing immediately 
prior to commencement of ART. PCR and viral load from the same individuals were linked 
by common personal identifiers. In order to have a both sensitive and specific linkage 
process, we chose to link the first PCR and viral load episodes with combinations of the 
hospital folder number, full name and date of birth in an iterative manner..  
In a sensitivity analysis, we derived two separate data sets representing (i) definitive and (ii) 
probable HIV PCR and HIVVL links in order to assess how the linkage algorithms may have 
influenced the study findings. An identical full surname or hospital folder number in 
combination with an identical date of birth were considered definitive match. Any 
combinations of partial surname date of birth and hospital folder number was considered 
probable matches (see supplementary figure 3). All successfully linked data were checked 
and any viral load that preceded the HIV PCR was removed from the final merged dataset. 
The delay in days between the first PCR and the first viral load was considered the 
approximate turnaround time for referring a PCR positive child to ART. PCR positive 











Statistical analysis was performed by statistical software StataSE (version 10.0, Statcorp, 
Texas, USA). Continuous variables were described using median and interquartile range 
(IQR) while proportions/percentages for were calculated for categorical variables. Odds 
ratios (OR) with 95% CI were calculated to demonstrate associations between categorical 
variables and stratified analyses were used to assess the effect of confounding. The study was 
approved by the Research and Ethics committee of the Faculty of Heath Sciences at 




HIV PCR results 
The search of NHLS CDW archive yielded 97235 electronic records of HIV PCR testing in 
the Western Cape Province. After removing duplicate records, non-diagnostic episodes, 
insufficient samples and unresolved tests, 94186 episodes remained. Of these remaining 
episodes, 2989 (3%) were performed on children two years or older and 7499 (8%) were 
repeat tests of previously tested children. The proportion of repeat testing increased from 
317/8653 in 2005 (4%) to 1163/10446 (11%) in 2011. Of the 83698 episodes of first time 
PCR from children less than 2 years of age, 6322 (7.6%) tested positive, 76956 (91.9%) 
tested negative and 418 (0.5%) had equivocal PCR results, (supplementary figure 1). The 
breakdown of the PCR results by year, gender, location and age is shown in table 1.  
 
In 2005, 303 health facilities were the sources of HIV PCR testing. This number rose to 341 
facilities in 2010. The turnaround time of the HIV PCR from date taken to date of test 
completion was reduced from 6 days (IQR 5-8days) to 2 days (IQR 1-2 days). While the 
number of HIV PCR testing gradually increased from 8000 to 16,000 per year, the proportion 
of PCR positive children had steadily declined from 12% in 2005 to 3% in 2011. The median 
age of first time HIV PCR testing was reduced from 4 months (IQR 3.1-5 months) in 2005 to 
1.5 months (IQR 1.4-2.1 months) in 2011. Thirteen percent of PCR testing came from tertiary 
hospitals where specialist paediatric services were available and 69% of PCR tests were from 
health facility in urban sub-districts in the City of Cape Town. No significant changes in the 
proportions of tertiary and urban PCR testing were observed over the 5 year study period. 
Infants from tertiary centres were much more likely to be PCR positive (OR 5.6, 95% CI 5.3-
5.9). 
 
HIV VL result 
The HIV viral load test requests extracted were put through a similar cleaning process as HIV 
PCR (supplementary figure 2). Only 34 140 of the 445 629 total electronic episodes of HIV 
viral load were completed diagnostic HIV VL for children less than 5 years of age. Of these, 
22487 were follow-up testing and thus only 11653 episodes were the first HIV viral load test 
of each child. Only these episodes were included in the PCR-VL linked analysis. The number 
of facility that test HIV viral load rose from 91 in 2005 to 220 in 2010. 
 
Linking PCR to VL episodes 
Using the definitive matching algorithm (dark grey boxes of supplementary figure 3), we 
found 3414/6322 (54%) children with first HIV PCR that had a matching episode of HIV 
viral load. Even with the expanded search criteria, we were only able to link a further 691 
probable matches (11%) resulting in 4105 (65%) total linked PCR-VL episodes (appendix 
figure 3). The relatively small proportion of probable links maintained its trend over the study 












Analysis of linked vs unlinked episodes 
The breakdown and number of linked versus unlinked positive PCR episodes are shown in 
table 2. Over the study period, the proportion of linked HIV PCR-VL episodes had increased 
from 54% in 2005 to 71% in 2010. Despite only contributing toward 13% of all PCR tests 
requested, the tertiary centres were responsible for 45% of the linked episodes. In particular, 
Cape Town’s largest paediatric hospital contributed 25% of all linked episodes. The linked 
rate of the tertiary centre (69%) was greater than that of the primary care centres (58%).  
 
The urban centre linkage rate (68%) is substantially better than the rural (50%) counterparts 
as well. The difference remained significant even after taking into account that the urban 
centres had more tertiary centres.  
 
Children greater than 2 months of age appeared to be less likely to be linked (OR 0.73, 95% 
CI 0.64-0.81) compared to younger infants. However, this association was likely confounded 
by the year of testing because after stratifying by year of testing, the proportion of linked 
children was very similar regardless of the age the children. 
 
Characteristics of the PCR-positive children referred for HIV care and treatment 
The median delay between PCR and VL decreased from 146 days in 2005 to 33 days in 2010. 
A notable decrease was observed in 2008. The delay was halved from 81 days in 2007 to 39 
days in 2008. Overall, 66% and 85% of the PCR-VL delays were less than 150 days and 365 
days respectively. In 2010, 83% of the PCR-VL delays were less than 150 days compared to 
the 50% in 2005. Two thirds of the PCR-VL delays in 2005 were less than 1 year. This figure 
was improved to 99% in 2010. 
 
The two major academic centres, Red Cross Children’s Memorial Hospital and Tygerberg 
Hospital, had much shorter delay between the testing of PCR and viral load. The median 
delays of children from these two hospitals were 13 days (IQR 5-68 days) compared to the 
rest of the children who had a median delay of 87 days (IQR 28-287 days). The overall trend 
of reductions in delays over calendar years was similar for the two academic centres and the 
rest of the facilities. The major reduction in delay during the 2007/2008 period was similarly 
observed in tertiary centres and non-tertiary centres. 
 
The median age of children undergoing their first HIV viral load testing was 96 days over the 
entire study period (IQR 50-169 days). This age had steadily decreased from 119 days in 
2005 to 60 days in 2010, with 2007/2008 being the year of the most significant decrease 
(from 103 days in 2007 to 73 days in 2008). However, the reduction in median age of HIV 
viral load was mainly observed outside the two academic centres (Figure 3). The age of first 
HIV viral load in Red Cross Children’s Memorial Hospital and Tygerberg hospital remained 




Improved PMTCT and EID 
Our data showed that the number of tested infant doubled over the six year period but the 
PCR positive rate was reduced from 12% to 3%. This steady decline speaks of the success of 
PMTCT in the province. Furthermore, the increased number of PCR testing facilities and 










substantially improved. With access to more facilities, the median age of children tested was 
reduced to 1.5 months in 2011. 
 
The few tertiary paediatric hospitals contributed to a high proportion of the total HIV PCR 
tests requested. As hospital in-patients are mostly children with severe disease, our stratified 
analysis showed that infants from tertiary centres were 5.6 times much more likely to be PCR 
positive. When focusing on non-tertiary centres cases only, the reduction in HIV infection 
remained significant (from 8.2% in 2005 to 2.8% in 2011). Similar significant reductions 
were seen in rural centres when urban facilities are excluded from the analysis. Therefore the 
effect of improved PMTCT and EID is not limited to the well resourced areas. The increased 
PCR positive proportion seen in older children is a result of different use of the HIV PCR. In 
the older children where the test is exclusively used for HIV diagnosis, the probability of 
PCR test being positive is much higher, representing children who previously missed EID 
and currently presenting with clinical illness.  
 
However, the increased testing capacity also resulted in increasing number of repeat testing 
within individual infants. The reason for the repeat HIV PCR tests is unclear, but may point 
towards a potential problem in returning the laboratory result to the caregiver of the infant 
and health care worker. Studies conducted in other parts of Africa showed that delay in the 
return of EID results to the clinics and failure of the caregivers to return for EID result is 
common8-11. 
  
Poor linkage of PCR positive infants to care 
Our linkage of HIV VL to PCR-positive test results shows that less than two-thirds of 
children testing positive go on to be enrolled in further HIV care and treatment services, as 
indicated by a subsequent HIV viral load. This proportion did not change appreciably even 
when the linkage criteria had been made less stringent (raising the possibility of false-positive 
linkages). However, this proportion increased over the 5 years study period with 71% of the 
HIV infected infants in 2010 had a subsequent HIV viral load.  
 
There are several possibilities which could result in the non-retention of PCR positive infants. 
First, the infant could have demised before the caregiver had an opportunity to attend a clinic 
where ART could be given to the infected infant. A Tanzanian study showed that 14% of 
caregivers received the EID result when their child had already demised10. Our manual search 
revealed that many of the HIV PCR positive episodes had other hospitalizations where 
additional inpatient investigations such as bacterial culture, TB cultures and tests for 
opportunistic infections were done. This symptomatic HIV disease was reflected even in the 
linked episodes where 45% originated from tertiary paediatric services. Second, the non-
retention could be due to the migration of infants and their mothers/caregivers. Due to better 
health infrastructure in the Western Cape, many pregnant mothers elect to travel from 
neighboring provinces, especially the Eastern Cape Province for the delivery and post natal 
services. It is possible that after the early infant testing, the HIV-positive results were never 
received and the subsequent follow up of HIV infection was done in another province. 
However there is little evidence that the levels of migration could account for the magnitude 
of the non-retention seen here. Third, multiple facility/folder numbers may be created of each 
infants and this would hamper the linking of the PCR to subsequent VL, resulting in under-
estimation of linked infants. Although this may potentially be an issue, the use of 
combinations of two further patient identifiers should capture any duplicate tests from the 











The time delay between HIV PCR and first HIV viral load decreased across calendar year. 
This is compatible with the change in WHO recommendation of infant treatment and steady 
increased access to ARV facilities. For the latter, the increase number of sites that submit 
HIV viral load request more than doubled over the study period, pointing towards increasing 
capacity for paediatric treatment. However, the median delay was still more than 1 month. 
Several factors contribute towards this long delay. First, although the median laboratory 
turnaround time of HIV PCR had been reduced to 2 days, this delay would still require the 
mother to return to the clinic to receive the result. Further to this, the clinics that provide 
ART is often separate from the ones that provide EID. This means visits to two clinics on at 
least three separate occasions are required before infected infants can be started on HAART. 
Even in the setting of urban Western Cape, transport cost to and from the clinics remain a 
significant financial constraint. A same day turnaround time EID and intergrated clinic 
service that provides PMTCT, EID and early infant ART would greatly reduce the delay. 
Second, because early ART is a relatively new service and the number of HIV infected 
infants is few, staff experience of providing ART to small infants may be limited. As capacity 
to provide early ART is increased, we can expect further reduction in the linkage to ART care 
due to increased paediatric ART sites. 
 
Interestingly, the reduction in the median age of infants undergoing first HIV viral load 
testing is mainly observed in the non-academic setting. The reduction in these non-academic 
primary care centres is explained by early ART initiated in asymptomatic newly diagnosed 
infant. The HIV viral load testing in the academic centres clearly represent a group of infants 
that either cannot gain access to PMTCT, EID or ART. The relative constant age of infants 
receiving HIV viral load testing at tertiary setting reflects the age in which infected children 
present to hospitals with their first manifestations of HIV.   
 
Limitations 
The differences between the probable and definitive linkage proportions were constant over 
the 5 calendar years points towards a systematic data linkage issue. The robustness of the 
PCR-viral load linkage process is entirely dependent on the quality of data written on and 
captured from the laboratory request forms. Although there were spelling errors and 
erroneous entries of personal identifiers, we believe our refined methodology would have 
captured a significant proportion of truly linked episodes of PCR and viral load. Unless 
totally non-matching personal identifiers are commonly used for the early infant diagnosis 
and subsequent HIV care, we do not believe this factor would account for much of the non-
retention. 
 
The time delay between PCR diagnosis and referral to care is likely a combination of delay in 
providing results to caregiver and delay in referral to care. Our methodology is unable to 
disentangle these two issues and review of individual patient folders or clinic registry is 




Despite its limitations, routine laboratory data is an important data source to evaluate PMTCT 
and infant ART program success. It is cost effectiveness and can be used to detect temporal 
trends in the background of changing international and local guidelines. It is a useful adjunct 
to cohorts data and routine district data collected by health facilities. Individual testing data 
from public pathology laboratory service can be used to validate the hypothesis generated 










proportions of HIV infected infants are decreasing dramatically, linkage of the infected 
infants to care remains a challenge. Further study to examine the cause of the low retention 















Table 1 Factors influencing HIV PCR result amongst first time testing of HIV exposed children 
    HIV PCR         
    positive negative % positive OR (crude) 95%CI   
Year 2005 1057 7594 12% ref    
 2006 861 6193 12% 1 0.91-1.10   
 2007 1170 11416 9% 0.74 0.67-0.80   
 2008 1097 13279 8% 0.59 0.54-0.65   
 2009 1035 14640 7% 0.51 0.46-0.56   
 2010 793 14931 5% 0.38 0.35-0.42   
 2011 311 8903 3% 0.25 0.22-0.29   
         
Gender female 3215 36648 8% ref    
 male 2848 36289 7% 0.89 0.85-0.94   
         
Tertiary site no 3757 68605 5% ref    
 yes 2567 8351 24% 5.61 5.31-5.93   
         
Cape Metro no 1994 23545 8% ref    
 yes 4330 53411 8% NS    
         
Age <2 months 1962 40823 5% ref    
 2-3 months 1608 16570 9% 2.02 1.89-2.16   
 4-5 months 1134 11765 9% 2.01 1.86-2.16   
 6-8 months 563 3586 14% 3.27 2.96-3.61   
 9-11 months 433 1998 18% 4.51 4.03-5.05   
 12-17 months 449 1711 21% 5.46 4.87-6.12   












Table 2 Factors influencing referral to care  as demonstrated by linked positive HIV PCR and Viral Load 
tests in HIV infected children less than five years of age in the public sector health facilities in the 
Western Cape Province of South Africa between January 2005 and December 2010 
 
  HIV PCR linked VL      
  Linked Not linked Total % linked OR (crude) 95%CI 
Year 2005 576 481 1057 54% ref  
 2006 483 378 861 56% 1.07 0.89-1.28 
 2007 662 508 1170 57% 1.09 0.92-1.29 
 2008 758 337 1095 69% 1.88 1.57-2.24 
 2009 703 332 1035 68% 1.77 1.48-2.11 
 2010 566 227 793 71% 2.08 1.71-2.53 
        
Gender female 1924 1134 3058 63% ref  
 male 1715 994 2709 63% 1.02 0.91-1.13 
        
Specialist 
Hospitals 
no 2061 1488 3549 58% ref  
 yes 1687 775 2462 69% 1.57 1.41-1.75 
        
Urban 
facilities 
no 954 936 1890 50% ref  
 yes 2794 1327 4121 68% 2.07 1.85-2.31 
        
Age at time 
of PCR 
<2 months 1230 592 1822 68% ref  
 >2 months 2518 1671 4189 60% 0.73 0.64-0.81 
 2-3 months 949 585 1534 62% 0.78 0.68-0.90 
 4-5 months 637 474 1111 57% 0.65 0.55-0.75 
 6-8 months 320 217 537 60% 0.71 0.58-0.87 
 9-11 months 249 167 416 60% 0.72 0.58-0.89 














Figure 1. Proportion of first PCR referred for subsequent viral load and the median delay 








































Referred for VL Not referred for VL Median delay from PCR to VL
 
 
Figure 2. The difference in age of baseline HIVVL children between specialist hospitals and 

















Median age of baseline HIVVL in non-academic centres
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Supplementary Figure 1. Processing and breakdown of HIV PCR testing episode between Jan 













Remove 2456 complete duplicate 
record  
Remove 170 external quality 
assurance (EQA) samples 
Remove 269 records with no 
results 
Remove 154 records with invalid 
test or insufficient sample 
All patient results of HIVPCR 
n=94186 
All electronic episodes of 
HIVPCR n=97235 
Remove 7499 non-first testing 
records 
Remove 2989 testing records or 
age ≥ 2 years  
HIV PCR results of previously 
untested children n=83696 
76956 PCR 
negative 











Supplementary Figure 2. Processing and breakdown of HIV VL testing episode between Jan 
2005 and July 2011 
 
 
Remove 138 (0.003%) complete 
duplicate records  
Remove 59 external quality 
assurance (EQA) samples 
Remove 2990 testing records or 
age > 5 years  
 
Remove 8 records with invalid 
result 
All HIV VL result of children ≤5 
n= 34140 
All electronic episodes of HIV 
VL n=445629 
Remove 22487 non-first HIV 
VL records 
HIV VL results of previously 
untested children n=11653 
3731+58 (32.5%) Lower 













Supplementary Figure 3. Processing of matching HIV PCR and HIV VL episodes. Dark grey 




401 records with no hospital ID  
Match by full name and date of birth 
First time positive HIVPCR n=6322 
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and date of birth 
Match 
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53 records with no 
date of birth  
No match 
N=2771 
Match by partial name 



















Match by partial name and 














Supplementary figure 4. Proportion of unlinked, probably linked and definitely linked PCR 
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Background: 
South Africa’s HIV prevalence is amongst the highest of the world’s The 2009 South African 
antenatal survey conducted by department of Health estimated that overall, 29% of mothers 
attending the antenatal clinics in South Africa were HIV infected. Prior to the antiretroviral 
therapy (ART) era, HIV infection amongst newborns result in significant burden of disease. 
This burden was indirectly observed in the high mortality of children under 5 and increased 
service demands in many secondary and tertiary paediatric care institutions.  
 
Risk of transmission to foetus and infant can be effectively reduced by using ART to 
temporarily suppress HIV viral replication. This intervention is commonly known as 
prevention of mother-to-child transmission, or PMTCT. In its simplest form, a single dose of 
Nevirapine given to the mother and her newborn child is able to reduce the HIV transmission 
by 47%. Western Cape had been in the forefront of implementing various PMTCT regimens. 
These programs had been quite effective in reducing the incidence of HIV infections among 
infants in the province. However, failure of this intervention does occur occasionally and 
despite the existence of a national PMTCT program, some infants does become HIV infected. 
 
Laboratory testing forms an important part of the PMTCT program because it is the most 
direct measurement of program success. Early infant diagnosis of HIV using polymerase 
chain reaction (PCR) allow us to identify the cases of PMTCT failure, and make sure the HIV 
infected children received the optimal care. According to archived NHLS laboratory data, 
approximately 30 HIV infections were detected in infant less than 3 month during the month 
of March in 2011. Prior to 2009, the South African guideline recommended that ART should 
only be started in these HIV infected children when disease progression had occurred. This 
recommendation was challenged by Violari and colleagues in the CHER study, as the study 
concluded that delaying ART in the perinatally infected children resulted in significant 
mortality. Thus the early ART strategy was adopted by the new national guideline in 2009 
and HIV infected infants, diagnosed by HIV PCR, would be fast track to ART. 
 
The implementation of this guideline is met with two major logistic difficulties. Firstly the 
timeous return of HIV PCR result to the mothers can be difficult in the resource poor setting. 
Infrastructure issues such as transport of specimen and speedy delivery of results to 
clinics/patients remain a concern in the Western Cape. Secondly, following diagnosis of HIV 
infection in the infant at the mother-child clinic, there is delay in referral to sites where ART 
could be initiated. In order to improve these services, data on the current program is essential. 
NHLS central data warehouse (CDW) archived data of all laboratory testing requests around 










be used to evaluate health programs. In this study we propose to use the CDW data to 




To evaluate the evolution of PMTCT between 2005 till 2011 in the Western Cape from the 
laboratory testing perspective. 
 
Objective: 
To describe trends in HIV PCR testing of infants from 2005-2011 according to: time period, 
test result and facility from which specimens were received 
To describe the proportion of PCR positive infants who subsequently initiate ART and the 
delays from PCR positive test result to ART initiation, during the years 2005-2011 
 
Pilot data/proof of concept study 
Children who had HIV PCR testing in Jan 2010 were reviewed and their subsequent HIVVL 
testing data was sought in this pilot study. The findings are as follows:  
 
Total children <18 months PCR pos 56 
Red Cross/Somerset/GRS/MOW PCR pos 31  
Of the PHC with pos PCR 
[56-
31=25] 
  HIVVL at same clinic 6 
  HIVVL at different PHC clinic 3 
  HIVVL  later at a hospital (symptomatic) 6 
  no further HIVVL done (LTF or died) 10 
 
As of Jan 2010, most HIV PCR positive children are still being diagnosed late in the tertiary 
hospital setting (31/56 are at hospital setting). This may reflect the presence of major gaps in 
PMTCT coverage in Western Cape and perinatal/postnatal HIV transmission is taking place.  
 
Of the PHC diagnosed positive result, only 9/25 had HIVVL at primary level subsequently. 
The rest either lost to our system or presented later at a hospital (mostly RXH) with 




This is a part service audit part descriptive study of the infant tested for HIV PCR in the 
Western Cape between 2005 and 2011. The Western Cape HIV PCR and HIV viral load 
testing data stored in NHLS central data warehouse (CDW) will be extracted. For individuals 
with positive or equivocal HIV PCR, searches will be performed in the HIV viral load 
database to determine whether these individual had been enrolled into HIV care at the same 
site or elsewhere.  
 
Data analysis: 
Describe the infant population tested for HIV PCR in Western Cape with regards to: 
1) Numbers of tests over time 
2) site of testing (primary vs tertiary care setting) 












Describe the testing and results of HIV PCR’s in Western Cape, specifically: 
1) turnaround time from sample taken to authorization of result 
2) proportion of positive result 
3) proportion of equivocal/indeterminant results 
 
Follow up positive HIV PCR results with HIV viral load data to identify  
1) The proportion of PCR positive children who have a subsequent HIV viral load 
(suggesting successful initiation of ART) 
2) The time delay from positive PCR result until first baseline HIV Viral load was 
performed 
3) How these proportions and delays vary according to (a) time period and (b) the site of 
testing and/or (c) the site of ART initiation (as indicated by subsequent viral load testing), 
with a broad distinction between tertiary hospitals and primary care settings 
 
Procedures 
Data will come from the CDW stored Western Cape ARV rollout program data between Jan 
2005 to June 2011, specifically HIV PCR and HIV viral load tested at Groote Schuur and 
Tygerberg Laboratories. All laboratory information captured by Disalab will be extracted, 
including laboratory of testing, laboratory number, patient name, date of birth, gender, 
location of request, date of request, test performed, date of test completion, and test result. 
Data will be managed in excel spreadsheet for searching purposes. A final dataset consisting 
of only relevant data merged on patient name and date of birth will be imported into STATA 
for data analysis. 
 
Ethics 
The proposed audit represents minimal risk to patients. All study data will be kept in 
password protected files, stored on limited-access computers behind firewall-protected 
servers on the UCT and NHLS networks. The routine datasets received from CDW will 
contain minimal patient identifiers (patient name, folder number, date of birth) required to 
identify subsequent viral loads taken on PCR positive children and to link maternal and infant 
specimens. However once the matching (of PCR and viral load data among infants, or 
maternal and infant results) is complete, we will strip the dataset of all identifiers prior to 
beginning data analysis. While there is no direct benefit to participants, there is potential 
indirect benefit of improved health care services for HIV-infected mothers and children that 
may emerge as a result of this research. 
 
Timelines 
June 2011 – submission of protocol to UCT ethics committee 
July 2011 – Receive ethics approval and submit the data request to CDW 
August 2011- obtaining the database of HIV viral load and CD4 from NHLS CDW and start 
the data search and data capturing process  
October – complete data analysis 
 
Budget 
We anticipate minimal costs associated with this research. Minor office costs will be paid 
from other funds by the Depts of Virology and Public Health. 
 
